Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug–drug interactions between PKC inhibitors and UGT1A6

Author： Volak L. P.   Court M. H.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.40, Iss.5, 2010-05, pp. : 306-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Many UDP-glucuronosyltransferases (UGTs) require phosphorylation by protein kinase C (PKC) for glucuronidation activity. Inhibition of UGT phosphorylation by PKC inhibitor drugs may represent a novel mechanism for drug–drug interactions. The potential for PKC-mediated inhibition of human UGT1A6, an isoform involved in the glucuronidation of drugs such as acetaminophen (paracetamol) and endogenous substrates including serotonin, was evaluated using various cell model systems. Of ten different PKC inhibitors screened for their effects on acetaminophen glucuronidation by human LS180 colon cells, only rottlerin (PKC δ selective inhibitor; IC50 = 9.0 ± 1.2 μM) and the non-selective PKC inhibitors (calphostin-C, curcumin and hypericin) decreased glucuronidation by more than 50%. Using UGT1A6-infected Sf9 insect cells, calphostin-C and hypericin showed three times more potent inhibition of serotonin glucuronidation in treated whole cells versus cell lysates. However, both curcumin and rottlerin showed significant direct inhibition and so (indirect) PKC effects could not be differentiated in this model system. Of nine PKC isoforms co-expressed with UGT1A6 in human embryonic kidney 293T cells only PKC δ increased protein-normalized UGT1A6-mediated serotonin glucuronidation significantly (by 63% ± 4%). These results identify an important role for PKC δ in UGT1A6-mediated glucuronidation and suggest that PKC δ inhibitors could interfere with glucuronidation of UGT1A6 substrates.

Related content

Nuclear UDP-Glucuronosyltransferases: Identification of UGT2B7 and UGT1A6 in Human Liver Nuclear Membranes

By Radominska-Pandya A.   Pokrovskaya I.D.   Xu J.   Little J.M.   Jude A.R.   Kurten R.C.   Czernik P.J.  

Archives of Biochemistry and Biophysics, Vol. 399, Iss. 1, 2002-03 ,pp. : 37-48 (12)

Elsevier

Access to resources Recommend Favorite

The importance of cysteine 126 in the human liver UDP-glucuronosyltransferase UGT1A6

By Senay C.   Jedlitschky G.   Terrier N.   Burchell B.   Magdalou J.   Fournel-Gigleux S.  

BBA - Protein Structure and Molecular Enzymology, Vol. 1597, Iss. 1, 2002-05 ,pp. : 90-96 (7)

Elsevier

Access to resources Recommend Favorite

Aryl Hydrocarbon Receptor-Inducible or Constitutive Expression of Human UDP Glucuronosyltransferase UGT1A6

By Munzel P.A.   Lehmkoster T.   Bruck M.   Ritter J.K.   Bock K.W.  

Archives of Biochemistry and Biophysics, Vol. 350, Iss. 1, 1998-02 ,pp. : 72-78 (7)

Elsevier

Access to resources Recommend Favorite

Tissue-Specific 2,3,7,8-Tetrachlorodibenzo- p -dioxin-Inducible Expression of Human UDP-Glucuronosyltransferase UGT1A6

By Munzel P.A.   Bookjans G.   Mehner G.   Lehmkoster T.   Bock K.W.  

Archives of Biochemistry and Biophysics, Vol. 335, Iss. 1, 1996-11 ,pp. : 205-210 (6)

Elsevier

Access to resources Recommend Favorite

cDNA Cloning and Characterization of the Human UDP Glucuronosyltransferase, UGT1A3

By Mojarrabi B.   Butler R.   Mackenzie P.I.  

Biochemical and Biophysical Research Communications, Vol. 225, Iss. 3, 1996-08 ,pp. : 785-790 (6)

Elsevier

Access to resources Recommend Favorite